Abstract
Summary
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor.
LPI (LP Information)' newest research report, the “Etanercept Drugs Industry Forecast” looks at past sales and reviews total world Etanercept Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Etanercept Drugs sales for 2023 through 2029. With Etanercept Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etanercept Drugs industry.
This Insight Report provides a comprehensive analysis of the global Etanercept Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etanercept Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Etanercept Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etanercept Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etanercept Drugs.
The global Etanercept Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Etanercept Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Etanercept Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Etanercept Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Etanercept Drugs players cover Amgen, Pfizer, 3SBIO and Celgen Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Etanercept Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Brands Drugs
Biosimilar Drugs
Segmentation by application
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Pfizer
3SBIO
Celgen Biopharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Etanercept Drugs market?
What factors are driving Etanercept Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Etanercept Drugs market opportunities vary by end market size?
How does Etanercept Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Etanercept Drugs Industry Forecast” looks at past sales and reviews total world Etanercept Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Etanercept Drugs sales for 2023 through 2029. With Etanercept Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Etanercept Drugs industry.
This Insight Report provides a comprehensive analysis of the global Etanercept Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Etanercept Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Etanercept Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Etanercept Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Etanercept Drugs.
The global Etanercept Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Etanercept Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Etanercept Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Etanercept Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Etanercept Drugs players cover Amgen, Pfizer, 3SBIO and Celgen Biopharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Etanercept Drugs market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Brands Drugs
Biosimilar Drugs
Segmentation by application
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amgen
Pfizer
3SBIO
Celgen Biopharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Etanercept Drugs market?
What factors are driving Etanercept Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Etanercept Drugs market opportunities vary by end market size?
How does Etanercept Drugs break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Etanercept Drugs Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Etanercept Drugs by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Etanercept Drugs by Country/Region, 2018, 2022 & 2029
2.2 Etanercept Drugs Segment by Type
2.2.1 Brands Drugs
2.2.2 Biosimilar Drugs
2.3 Etanercept Drugs Sales by Type
2.3.1 Global Etanercept Drugs Sales Market Share by Type (2018-2023)
2.3.2 Global Etanercept Drugs Revenue and Market Share by Type (2018-2023)
2.3.3 Global Etanercept Drugs Sale Price by Type (2018-2023)
2.4 Etanercept Drugs Segment by Application
2.4.1 Rheumatoid Arthritis
2.4.2 Juvenile Idiopathic Arthritis
2.4.3 Psoriatic Arthritis
2.4.4 Ankylosing Spondylitis
2.4.5 Other
2.5 Etanercept Drugs Sales by Application
2.5.1 Global Etanercept Drugs Sale Market Share by Application (2018-2023)
2.5.2 Global Etanercept Drugs Revenue and Market Share by Application (2018-2023)
2.5.3 Global Etanercept Drugs Sale Price by Application (2018-2023)
3 Global Etanercept Drugs by Company
3.1 Global Etanercept Drugs Breakdown Data by Company
3.1.1 Global Etanercept Drugs Annual Sales by Company (2018-2023)
3.1.2 Global Etanercept Drugs Sales Market Share by Company (2018-2023)
3.2 Global Etanercept Drugs Annual Revenue by Company (2018-2023)
3.2.1 Global Etanercept Drugs Revenue by Company (2018-2023)
3.2.2 Global Etanercept Drugs Revenue Market Share by Company (2018-2023)
3.3 Global Etanercept Drugs Sale Price by Company
3.4 Key Manufacturers Etanercept Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etanercept Drugs Product Location Distribution
3.4.2 Players Etanercept Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Etanercept Drugs by Geographic Region
4.1 World Historic Etanercept Drugs Market Size by Geographic Region (2018-2023)
4.1.1 Global Etanercept Drugs Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Etanercept Drugs Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Etanercept Drugs Market Size by Country/Region (2018-2023)
4.2.1 Global Etanercept Drugs Annual Sales by Country/Region (2018-2023)
4.2.2 Global Etanercept Drugs Annual Revenue by Country/Region (2018-2023)
4.3 Americas Etanercept Drugs Sales Growth
4.4 APAC Etanercept Drugs Sales Growth
4.5 Europe Etanercept Drugs Sales Growth
4.6 Middle East & Africa Etanercept Drugs Sales Growth
5 Americas
5.1 Americas Etanercept Drugs Sales by Country
5.1.1 Americas Etanercept Drugs Sales by Country (2018-2023)
5.1.2 Americas Etanercept Drugs Revenue by Country (2018-2023)
5.2 Americas Etanercept Drugs Sales by Type
5.3 Americas Etanercept Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etanercept Drugs Sales by Region
6.1.1 APAC Etanercept Drugs Sales by Region (2018-2023)
6.1.2 APAC Etanercept Drugs Revenue by Region (2018-2023)
6.2 APAC Etanercept Drugs Sales by Type
6.3 APAC Etanercept Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Etanercept Drugs by Country
7.1.1 Europe Etanercept Drugs Sales by Country (2018-2023)
7.1.2 Europe Etanercept Drugs Revenue by Country (2018-2023)
7.2 Europe Etanercept Drugs Sales by Type
7.3 Europe Etanercept Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Etanercept Drugs by Country
8.1.1 Middle East & Africa Etanercept Drugs Sales by Country (2018-2023)
8.1.2 Middle East & Africa Etanercept Drugs Revenue by Country (2018-2023)
8.2 Middle East & Africa Etanercept Drugs Sales by Type
8.3 Middle East & Africa Etanercept Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etanercept Drugs
10.3 Manufacturing Process Analysis of Etanercept Drugs
10.4 Industry Chain Structure of Etanercept Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etanercept Drugs Distributors
11.3 Etanercept Drugs Customer
12 World Forecast Review for Etanercept Drugs by Geographic Region
12.1 Global Etanercept Drugs Market Size Forecast by Region
12.1.1 Global Etanercept Drugs Forecast by Region (2024-2029)
12.1.2 Global Etanercept Drugs Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Etanercept Drugs Forecast by Type
12.7 Global Etanercept Drugs Forecast by Application
13 Key Players Analysis
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Etanercept Drugs Product Portfolios and Specifications
13.1.3 Amgen Etanercept Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Etanercept Drugs Product Portfolios and Specifications
13.2.3 Pfizer Etanercept Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 3SBIO
13.3.1 3SBIO Company Information
13.3.2 3SBIO Etanercept Drugs Product Portfolios and Specifications
13.3.3 3SBIO Etanercept Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 3SBIO Main Business Overview
13.3.5 3SBIO Latest Developments
13.4 Celgen Biopharma
13.4.1 Celgen Biopharma Company Information
13.4.2 Celgen Biopharma Etanercept Drugs Product Portfolios and Specifications
13.4.3 Celgen Biopharma Etanercept Drugs Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Celgen Biopharma Main Business Overview
13.4.5 Celgen Biopharma Latest Developments
14 Research Findings and Conclusion